Search

Search Constraints

You searched for: Author/Creator Douglas, Steven D.

Search Results

7. Pharmacokinetics, Safety, and 48-Week Efficacy of Oral Raltegravir in HIV-1–Infected Children Aged 2 Through 18 Years. (21st October 2013)

9. Reduction of soluble CD163, substance P, programmed death 1 and inflammatory markers: phase 1B trial of aprepitant in HIV-1-infected adults. (15th May 2015)